IL1B and melanoma: In fact, it was shown that in melanoma-initiating cells ABCB5 controls UK-IL1-β secretion, which acts to maintain slow-cycling, chemoresistant cells through a signaling pathway mediated by the IL-1/βIL-8/CXCR1 signaling axis [226].